Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from NRTIs to maraviroc for mitochondrial toxicity and immune activation
2010-023192-26Phase 4Active
- Sponsor
- mib Dienstleistungsgesellschaft
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of maraviroc in human immunodeficiency virus infection (HIV) (2 arms), sponsored by mib Dienstleistungsgesellschaft. Started Jan 2011; status: active.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-023192-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023192-26.